| Association of hippocampal glutamate levels with adverse outcomes in individuals at clinical high risk for psychosis MG Bossong, M Antoniades, M Azis, C Samson, B Quinn, I Bonoldi, ... JAMA psychiatry 76 (2), 199-207, 2019 | 81 | 2019 |
| Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicentre Studies-PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice. Schizophrenia Bulletin 46 (6), 432-441, 2020 | 70 | 2020 |
| Verbal learning and hippocampal dysfunction in schizophrenia: A meta-analysis M Antoniades, T Schoeler, J Radua, I Valli, P Allen, MJ Kempton, ... Neuroscience & Biobehavioral Reviews 86, 166-175, 2018 | 68 | 2018 |
| Longitudinal alterations in motivational salience processing in ultra-high-risk subjects for psychosis A Schmidt, M Antoniades, P Allen, A Egerton, CA Chaddock, S Borgwardt, ... Psychological medicine 47 (2), 243-254, 2017 | 41 | 2017 |
| Brain age prediction in schizophrenia: Does the choice of machine learning algorithm matter? WH Lee, M Antoniades, HG Schnack, RS Kahn, S Frangou Psychiatry Research: Neuroimaging 310, 111270, 2021 | 32 | 2021 |
| Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study OD Howes, I Bonoldi, RA McCutcheon, M Azis, M Antoniades, M Bossong, ... Neuropsychopharmacology 45 (4), 641-648, 2020 | 32 | 2020 |
| Neural circuitry of novelty salience processing in psychosis risk: association with clinical outcome G Modinos, P Allen, A Zugman, D Dima, M Azis, C Samson, I Bonoldi, ... Schizophrenia bulletin 46 (3), 670-679, 2020 | 30 | 2020 |
| Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis C Davies, Y Paloyelis, G Rutigliano, M Cappucciati, A De Micheli, ... Neuropsychopharmacology 44 (7), 1300-1309, 2019 | 30 | 2019 |
| Cortical and subcortical neuroanatomical signatures of schizotypy in 3004 individuals assessed in a worldwide ENIGMA study M Kirschner, B Hodzic-Santor, M Antoniades, I Nenadic, T Kircher, A Krug, ... Molecular psychiatry 27 (2), 1167-1176, 2022 | 29 | 2022 |
| Association of adverse outcomes with emotion processing and its neural substrate in individuals at clinical high risk for psychosis G Modinos, MJ Kempton, S Tognin, M Calem, L Porffy, M Antoniades, ... JAMA psychiatry 77 (2), 190-200, 2020 | 29 | 2020 |
| Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes G Modinos, A Richter, A Egerton, I Bonoldi, M Azis, M Antoniades, ... Neuropsychopharmacology 46 (8), 1468-1474, 2021 | 28 | 2021 |
| Personalized estimates of brain structural variability in individuals with early psychosis M Antoniades, SS Haas, A Modabbernia, O Bykowsky, S Frangou, ... Schizophrenia bulletin 47 (4), 1029-1038, 2021 | 20 | 2021 |
| Sex differences in predictors and regional patterns of brain age gap estimates N Sanford, R Ge, M Antoniades, A Modabbernia, SS Haas, HC Whalley, ... Human Brain Mapping 43 (15), 4689-4698, 2022 | 16 | 2022 |
| Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis H Baldwin, J Radua, M Antoniades, SS Haas, S Frangou, I Agartz, P Allen, ... Translational psychiatry 12 (1), 297, 2022 | 12 | 2022 |
| Verbal memory performance predicts remission and functional outcome in people at clinical high-risk for psychosis EP Hedges, H Dickson, S Tognin, G Modinos, M Antoniades, ... Schizophrenia Research: Cognition 28, 100222, 2022 | 12 | 2022 |
| Psychosis brain subtypes validated in first-episode cohorts and related to illness remission: results from the PHENOM consortium DB Dwyer, GB Chand, A Pigoni, A Khuntia, J Wen, M Antoniades, ... Molecular psychiatry 28 (5), 2008-2017, 2023 | 10 | 2023 |
| Systematic review and multi-modal meta-analysis of magnetic resonance imaging findings in 22q11. 2 deletion syndrome: Is more evidence needed? C Scarpazza, GM Lattanzi, M Antoniades, F Di Fabio, G Sartori, ... Neuroscience & biobehavioral reviews 107, 143-153, 2019 | 10 | 2019 |
| Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function P Allen, EJ Hird, N Orlov, G Modinos, M Bossong, M Antoniades, ... Translational psychiatry 11 (1), 579, 2021 | 9 | 2021 |
| AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and … CHY Fu, G Erus, Y Fan, M Antoniades, D Arnone, SR Arnott, T Chen, ... BMC psychiatry 23 (1), 59, 2023 | 4 | 2023 |
| Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo CHY Fu, M Antoniades, G Erus, JA Garcia, Y Fan, D Arnone, SR Arnott, ... Nature Mental Health, 1-13, 2024 | 2 | 2024 |
